Moors & Cabot’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4M | Sell |
18,533
-20,983
| -53% | -$1.5M | 0.06% | 284 |
|
|
2025
Q4 | $2.44M | Sell |
39,516
-333
| -0.8% | -$19.6K | 0.1% | 184 |
|
|
2025
Q3 | $2.34M | Sell |
39,849
-1,729
| -4% | -$101K | 0.1% | 184 |
|
|
2025
Q2 | $2.42M | Sell |
41,578
-185
| -0.4% | -$10.5K | 0.11% | 171 |
|
|
2025
Q1 | $2.07M | Sell |
41,763
-2,228
| -5% | -$114K | 0.11% | 178 |
|
|
2024
Q4 | $1.97M | Sell |
43,991
-775
| -2% | -$36.8K | 0.09% | 184 |
|
|
2024
Q3 | $2.15M | Sell |
44,766
-511
| -1% | -$24.6K | 0.11% | 176 |
|
|
2024
Q2 | $2.31M | Sell |
45,277
-1,921
| -4% | -$105K | 0.12% | 159 |
|
|
2024
Q1 | $2.56M | Buy |
47,198
+1,052
| +2% | +$54.8K | 0.14% | 143 |
|
|
2023
Q4 | $2.6M | Sell |
46,146
-1,185
| -3% | -$67K | 0.16% | 133 |
|
|
2023
Q3 | $2.92M | Buy |
47,331
+1,510
| +3% | +$95.5K | 0.2% | 114 |
|
|
2023
Q2 | $2.71M | Buy |
45,821
+1,164
| +3% | +$74.1K | 0.18% | 127 |
|
|
2023
Q1 | $3.3M | Buy |
44,657
+100
| +0.2% | +$7.72K | 0.23% | 106 |
|
|
2022
Q4 | $3.25M | Buy |
44,557
+1,045
| +2% | +$82.6K | 0.23% | 102 |
|
|
2022
Q3 | $3.63M | Buy |
43,512
+975
| +2% | +$83.9K | 0.28% | 82 |
|
|
2022
Q2 | $3.39M | Buy |
42,537
+2,020
| +5% | +$196K | 0.24% | 94 |
|
|
2022
Q1 | $4.21M | Sell |
40,517
-14,497
| -26% | -$1.2M | 0.26% | 91 |
|
|
2021
Q4 | $4.14M | Sell |
55,014
-58,058
| -51% | -$4.06M | 0.25% | 87 |
|
|
2021
Q3 | $7.3M | Buy |
113,072
+55,816
| +97% | +$3.41M | 0.46% | 43 |
|
|
2021
Q2 | $3.47M | Sell |
57,256
-20
| -0% | -$1.18K | 0.24% | 92 |
|
|
2021
Q1 | $3.08M | Sell |
57,276
-2,095
| -4% | -$114K | 0.24% | 96 |
|
|
2020
Q4 | $2.85M | Buy |
59,371
+4,261
| +8% | +$188K | 0.24% | 93 |
|
|
2020
Q3 | $2.16M | Buy |
55,110
+1,830
| +3% | +$66.6K | 0.2% | 109 |
|
|
2020
Q2 | $1.71M | Buy |
53,280
+10,661
| +25% | +$371K | 0.18% | 126 |
|
|
2020
Q1 | $1.45M | Buy |
42,619
+7,018
| +20% | +$281K | 0.21% | 107 |
|
|
2019
Q4 | $1.71M | Buy |
35,601
+48
| +0.1% | +$2.32K | 0.17% | 135 |
|
|
2019
Q3 | $1.77M | Buy |
35,553
+808
| +2% | +$41.2K | 0.2% | 126 |
|
|
2019
Q2 | $1.85M | Sell |
34,745
-11,930
| -26% | -$623K | 0.23% | 107 |
|
|
2019
Q1 | $2.45M | Buy |
46,675
+436
| +0.9% | +$22.7K | 0.33% | 84 |
|
|
2018
Q4 | $2.19M | Sell |
46,239
-1,636
| -3% | -$85.3K | 0.34% | 80 |
|
|
2018
Q3 | $2.77M | Buy |
47,875
+1,426
| +3% | +$78.9K | 0.34% | 76 |
|
|
2018
Q2 | $2.53M | Buy |
46,449
+1,977
| +4% | +$98.1K | 0.34% | 77 |
|
|
2018
Q1 | $2.1M | Buy |
+44,472
| New | +$2.23M | 0.28% | 93 |
|
Other funds holding NTR
VCM
Moors & Cabot's NTR Position: Q1 2026 in Review
Moors & Cabot reduced its Nutrien (NTR) stake by 53% in Q1 2026, selling an estimated $1.5M and leaving 18,533 shares worth $1.4M. The position accounts for 0.06% of the portfolio, ranked #284.
Moors & Cabot first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $7.3M in Q3 2021. 748 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Moors & Cabot held 18,533 shares of Nutrien worth $1.4M as of Q1 2026.
- Moors & Cabot sold 20,983 Nutrien shares in Q1 2026, an estimated $1.5M.
- Nutrien made up 0.06% of Moors & Cabot's portfolio in Q1 2026, its #284 holding.
- Moors & Cabot first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
- Moors & Cabot's Nutrien position peaked at $7.3M in Q3 2021.
- 748 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.